Edge Finco
Edge Finco plc is a specialized financing, treasury management, and debt-issuing subsidiary established for the Edge pharmaceutical group (historically linked to Neopharma and European pharmaceutical manufacturing operations). The company issues corporate bonds and debt instruments in international capital markets to fund the strategic investments, acquisition programs, and refinancing requirements of the broader Edge pharmaceutical manufacturing enterprise. The corporate group specializes in the development, manufacturing, and global commercial distribution of generic and branded prescription pharmaceuticals across therapeutic categories. Cash flows servicing Edge Finco's debt obligations are derived directly from intercompany loan repayments backed by the operating cash flows of the group's pharmaceutical manufacturing business. Edge Finco plc is headquartered in the United Kingdom, operating as a dedicated financing vehicle.
5 of the funds FundTelligence covers report a position in Edge Finco.
- Legal name
- Edge Finco PLC
- Sector
- Financials
- Country
- United Kingdom
- Funds holding it
- 5
Funds holding Edge Finco
- Nordea European High Yield Bond — Nordea Funds · 0.8 % (full portfolio disclosed, September 2026)
- Nordea European High Yield Opportunities — Nordea Funds · 0.74 % (full portfolio disclosed, September 2026)
- Nordea International High Yield Opportunities — Nordea Funds · 0.39 % (full portfolio disclosed, September 2026)
- Danske Invest Global High Yield Obligasjon — Danske Invest · 0.34 % (full portfolio disclosed, September 2026)
- Mercer Global High Yield Bond Fund — Mercer · 0.14 % (full portfolio disclosed, December 2025)